1. Home
  2. AERT vs IGC Comparison

AERT vs IGC Comparison

Compare AERT & IGC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Aeries Technology Inc.

AERT

Aeries Technology Inc.

SELL

Current Price

$6.25

Market Cap

39.0M

ML Signal

SELL

Logo IGC Pharma Inc.

IGC

IGC Pharma Inc.

SELL

Current Price

$0.25

Market Cap

32.0M

Sector

Health Care

ML Signal

SELL

Company Overview

Basic Information
Metric
AERT
IGC
Founded
2012
2005
Country
Singapore
United States
Employees
N/A
N/A
Industry
Professional Services
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
39.0M
32.0M
IPO Year
2021
2005

Fundamental Metrics

Financial Performance
Metric
AERT
IGC
Price
$6.25
$0.25
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
15.5K
★ 637.8K
Earning Date
11-09-2026
11-05-2026
Dividend Yield
N/A
N/A
EPS Growth
★ 110.87
59.09
EPS
★ 0.27
N/A
Revenue
★ $70,014,000.00
$1,271,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
$24.43
★ N/A
Revenue Growth
★ N/A
N/A
52 Week Low
$2.08
$0.24
52 Week High
$7.96
$0.45

Technical Indicators

Market Signals
Indicator
AERT
IGC
Relative Strength Index (RSI) 45.99 33.22
Support Level $6.25 $0.24
Resistance Level $7.30 $0.30
Average True Range (ATR) 0.52 0.01
MACD -0.08 -0.00
Stochastic Oscillator 32.34 0.67

Price Performance

Historical Comparison
AERT
IGC

About AERT Aeries Technology Inc.

Aeries Technology Inc is a professional and management services partner offering a range of management consultancy services for private equity sponsors and their portfolio companies with engagement models that are designed to provide a mix of deep vertical specialty, functional expertise, and digital systems and solutions to scale, optimize and transform a client's business operations. It supports and drives its client's growth across the globe by providing a range of management consultancy services involving professional advisory services and operations management services to build and manage dedicated delivery centers in appropriate locations based on customer business needs. It has more than 40 clients spanning across industry segments.

About IGC IGC Pharma Inc.

IGC Pharma Inc develops cannabinoid-based formulations for treating diseases and conditions, including, but not limited to, Alzheimer's disease, period cramps, premenstrual syndrome, and chronic pain. The company has investigational drug assets targeting Alzheimer's disease, IGC-AD1, IGC-M3, IGC-1C, and TGR-63, which have demonstrated in Alzheimer's cell lines the potential to be effective in suppressing or ameliorating key hallmarks of Alzheimer's disease, such as plaques or tangles.

Share on Social Networks: